Foster political, advocacy for TB vaccines R&D, and enhanced community engagementFriday, August 9, 2024Acceptability, Community engagementRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South AfricaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
An investment case for new tuberculosis vaccinesFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO evidence considerations for vaccine policy development for tuberculosis vaccines intended for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
A global framework to prepare for country introduction of new TB vaccines for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO preferred product characteristics for new tuberculosis vaccineFriday, August 9, 2024Availability, Policy and frameworksRead More
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyFriday, August 9, 2024Availability, Epidemiological impactRead More
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
